A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S T | U | V | W | X | Z

Articles are indexed by drug names, trade names and disease terms. Bold entries refer to major references. Use the navigation above to navigate through this index. Use the reference links (i.e. 2:7) to see the sources.

Key Word / Drug Name
Issue #: Page #
5-nitroimidazole2:7

A

abatacept2:9
acne1:1-5; 6:1-6, 7-10,12
acute bacterial skin & skin structure infections2:7
adalimumab2:8,9
Adcetris®1:10
adjuvant therapy4:10
aerosol4:5-9
afamelanotide6:1-6
aging skin1:1-5
alitretinoin
allergic contact dermatitis6:1-6
alopecia areata3:5-9; 6:12
alpha-1A-adrenoceptor agonist2:9
alpha-galactosidase2:4-7; 5:10
alpha-melanocyte stimulating hormone6:7-10
Amgevita™2:8,9
Amphora®3:10
anesthetic patch3:10
angiokeratoma1:4-5
anthraquinone4:10; 5:10
antibiotic1:7; 2:7; 6:12
anti-cancer4:10; 5:10; 6:10
antihistamines3:1-4
anti-immunoglobulin E antibody3:1-4
anti-inflammatory4:10; 5:10
antiviral5:10
atopic dermatitis1:1-5; 2:7; 3:5-9; 5:10
autologous fibroblast gene therapy6:12
avelumab2:7

B

bacterial vaginosis2:7
Bavencio®2:7
Baxdela™2:7
benzoquinone ubidecarenone4:10
Berinert®1:6-8
betamethasone dipropionate4:5-9
binimetinib5:10
biologic therapy1:10; 2:1-3; 3:1-4; 4:10
biosimilar2:8
botulinum toxin type A6:12
bradykinin B2 receptor antagonist1:6-8
BRAF inhibitor4:10; 5:10
Braftovi®5:10
brentuximab vedotin1:10; 2:10
brodalumab2:1-3,8
Bryhali™6:12

C

C1 inhibitor1:6-8; 2:8
calcipotriol5:5-9
cannabinoids6:1-6
CC chemokine receptor 4 (CCR4)5:10
CCP-0204:10
cemiplimabrwlc6:12
certolizumab pegol4:10
chlamydia3:10
chronic hand dermatitis3:1-4
chronic idiopathic urticaria3:1-4; 5:5-8
chronic pruritus5:5-8
chronic spontaneous urticaria3:1-4
Churg-Strauss syndrome2:9
Cinryze®1:6-8
coenzyme Q104:10
conestat alfa1:6-8
Consentyx®3:10; 5:10
CoolSculpting®2:10
corticosteroids3:2-3; 4:5-9
crisaborole5:10
cryolipolysis2:10
cutaneous squamous cell carcinoma6:12
cutaneous T cell lymphoma (CTCL)1:10; 2:7,10; 5:10
cyclosporin A3:3
Cyltezo®2:8

D

dabrafenib4:10
delafloxacin2:7
dermal filler2:7; 4:10
dermatitis6:1-6
dermatomyositis3:5-9
DeScribe® PFD Patch2:9
diacerein4:10; 5:10
diet and skin1:1-5
dietary triggers1:1-5
dimethyl fumarate2:8
dorsal root ganglion5:5-8
drug delivery4:5-9
dupilumab2:7; 5:5-8
Dupixent®2:7; 5:5-8

E

ecallantide1:6-8
eczema; 5:10
encorafenib5:10
endocannabinoid6:1-6
eosinophilic granulomatosis with polyangiitis2:9,10
epidermolysis bullosa4:10; 5:10
erythema2:9
erythropoietic protoporphyria (EPP)6:7-10
Eskata™2:9,10
Eucrisa™5:10

F

Fabry disease2:4-6,7; 5:10
fibrosis6:1-6
Firazyr®1:6-8
fluoroquinolone2:7
foam4:5-9

G

Galafold™2:7; 5:10
Gardasil®96:12
gene expression testing5:1-4
glycopyrronium tosylate5:10
golimumab1:10; 2:9
graft-versus-host disease3:5-9
guselkumab2:8

H

Haegarda®2:8
Hailey-Hailey disease6:7-10
halobetasol propionate6:12
hand dermatitis/eczema4:1-4
hereditary angioedema1:6-8; 2:8
herpes zoster1:10; 2:8
hidradenitis suppurativa2:8,9
human papillomavirus (HPV)6:12
Humira®2:8
hyaluronic acid2:7; 4:10
hydrogen peroxide2:9,10
hyperhidrosis5:10

I

icatibant1:6-8
Ilumya™3:10
immune-modulatory agents5:5-8
Imraldi®2:8
inflammatory skin disease6:1-6
infliximab2:8,9
interleukin-1 (IL-1)4:10; 5:10
interleukin-12 (IL-12)1:10
interleukin-13 (IL-13)2:7; 5:5-8
interleukin-17 (IL-17)2:1-3,8,9
interleukin-17A (IL-17A)2:1-3,8,9; 3:10; 4:10; 5:10
interleukin-23 (IL-23)1:10; 2:8; 3:10
interleukin-31 (IL-31)5:5-8
interleukin-4 (IL-4)2:7; 5:5-8
interleukin-4Ra (IL-4Ra) 5:5-8
interleukin-5 (IL-5)2:9,10
itch5:5-8
ixekizumab2:9; 4:10
Ixifi™2:8,9

J

JAK inhibitors3:5-9; 5:5-8; 6:12
Jakafi®/Jakavi®3:5-9; 5:5-8
JAK-STAT pathway3:5-9; 5:5-8
Janus kinase inhibitors3:5-9; 5:5-8; 6:12
Juvéderm®2:7

K

Kalbitor®1:6-8
kinase inhibitor5:10

L

Libtayo®6:12
lidocaine3:10

M

matrix metalloproteinase 1 (MMP-1)6:12
MEK inhibitor5:10
Mekinist®4:10
Mektovi®5:10
melanocortin 1 receptor (MC1R)6:7
melanoma2:10; 4:10; 5:1-4,10; 6:1-6
mempolizumab2:9,10
Merkel cell carcinoma2:7
methicillin resistant Staphylococcus aureus (MRSA)2:7
migalastat2:7; 5:10
mogamulizumabkpkc5:10
monoclonal antibody1:1-3; 2:1-3,7-9; 3:1-4,10; 4:10; 5:5-8,10; 6:12
mycosis fungoides1:10; 2:7; 5:10

N

nemolizumab5:5-8
neuro-immune interaction5:5-8
non-melanoma skin cancer6:1-6
Nucala®2:9

O

omalizumab3:1-4
onabotulinumtoxinA1:10
Orencia®2:9
orthopoxvirus5:10
oxymetazoline hydrochloride2:9

P

pain2:4
palmitoylethanolamide6:1-6
pemphigus vulgaris4:10
perfluorodecalin2:10
peripheral sensory neuron5:6
PF-066516006:12
phosphodiesterase-4 inhibitor (PDE-4)5:10
Pigmented Lesions Assay (PLA)2:10;
polymorphic light eruption (PMLE)6:7-10
postherpetic neuralgia3:10
Poteligeo®5:10
prabotulinumtoxinA6:12
primary cutaneous anaplastic large cell lymphoma (PCALCL)1:102:7
programmed cell death protein 1 (PD-1)2:7; 6:12
programmed cell death-ligand 1 (PD-L1)2:7
pruritus5:5-8; 6:1-6
psoriasis1:1-5,10; 2:1-3,8,9; 3:5-9,10; 4:5-9,10; 6:12
psoriatic arthritis1:10; 2:8,9; 3:6-7; 5:10

Q

Qbrexza®5:10

R

Remicade®2:8,9
Restylane®1:10; 4:10
retinoid4:1-4; 6:12
Revanesse® Ultra2:7
RHA®2/RHA®3/RHA®42:7
rhein4:10; 5:10
Rhofade™2:9
Rhucin®1:6-8
rhytide2:7; 6:12
Rituxan®4:10
rituximab4:10
rosacea1:1-52:9
ruxolitinib3:5-9; 5:5-8

S

sarecycline hydrochloride6:12
scalp psoriasis3:10
Scenesse®6:7-10
scleroderma6:12
sclerosis6:1-6
seborrheic keratosis2:9,10
secnidazole1:7
secukinumab3:10; 5:10
Seysara™6:12
Sézary syndrome5:10
shingles1:10
Shingrix®1:10; 2:8
Siliq™2:8
Simponi Aria®1:10
Skilarence®2:8
skin cancer2:10; 4:10; 5:1-4,10; 6:1-6
small molecule agent5:5-8,10; 6:12
smallpox5:10
solar urticarial6:7-10
Solosec™2:7
squamous cell carcinoma6:12
standard of care5:1-4
Stelara®1:10
sweating abnormalities2:4-6; 5:10

T

Tafinlar®4:10
Talz®2:9; 4:10
tattoo removal2:10
tecovirimat5:10
telangiectasia2:4-6
tetracycline6:12
tetrahydrocannabinol (THC)6:1-6
tildrakizumabasmn3:10
Toctino®4:1-4
tofacifinib2:9; 3:5-9; 5:5-8
topical formulations4:5-9
Tpoxx®5:10
trametinib4:10
Tremfya™2:8
tretinoin6:12
tumor necrosis factor-alpha (TNF-alpha)1:10; 4:10
tyrosine kinase 2 (TYK2)3:5-9

U

ubidecarenone4:10
ultraviolet (UV) damage2:9;4:10
urticaria3:1-4; 6:7-10
ustekinumab1:10

V

vaccine1:10; 2:8; 6:12
vasculitis2:9,10
vehicle4:5-9
vitamin A; 6:12
vitamin D4:5-9
vitiligo3:5-9; 6:7-10
Volift™/Vollure™2:7

W

wrinkles2:7; 6:12

X

Xeljanz®2:9; 3:5-9; 5:5-8
Xolair®3:1-4

Z

ZTlido™3:10

Purchase Article PDF for $1.99